Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review
Abstract Background The effectiveness of radioiodine therapy (RAI) in reducing recurrence and improving overall survival in differentiated thyroid carcinoma (DTC) remains debated. This systematic review evaluates the impact of RAI on DTC recurrence and survival. Methods A comprehensive search was co...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | Journal of the Egyptian National Cancer Institute |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43046-025-00293-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849325945375162368 |
|---|---|
| author | Bima Indra Nur Qodir Didit Pramudhito Legiran Legiran Zen Hafy Andi M Iqbal Yusran |
| author_facet | Bima Indra Nur Qodir Didit Pramudhito Legiran Legiran Zen Hafy Andi M Iqbal Yusran |
| author_sort | Bima Indra |
| collection | DOAJ |
| description | Abstract Background The effectiveness of radioiodine therapy (RAI) in reducing recurrence and improving overall survival in differentiated thyroid carcinoma (DTC) remains debated. This systematic review evaluates the impact of RAI on DTC recurrence and survival. Methods A comprehensive search was conducted across PubMed, ScienceDirect, Web of Science, CINAHL, and Tripdatabase, including studies from inception to August 2024. Only studies published in English with full-text availability were included. Risk of bias was assessed using the Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions (RoBANS 2). Results Nine studies were included, involving 161,703 participants (36,658 men and 125,045 women). The studies were geographically diverse, with four from the American continent, three from Asia, and two from Europe. RAI doses ranged from 30 to 300 mCi, with 30 mCi and 100 mCi being the most common. Five studies found that RAI reduced recurrence, while two found no significant effect. The median time to recurrence ranged from 10 months to 15 years, with most studies indicating a 1–2-year median. Regarding overall survival, two studies reported improvement with successful RAI therapy, while two found no significant impact. Conclusion RAI therapy shows potential in reducing recurrence in DTC, particularly within the first 2-year post-treatment, but its effect on overall survival remains unclear. Further high-quality research is necessary to confirm these findings and guide clinical practice. |
| format | Article |
| id | doaj-art-437a994d14c74de1a49e565ea134556a |
| institution | Kabale University |
| issn | 2589-0409 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Journal of the Egyptian National Cancer Institute |
| spelling | doaj-art-437a994d14c74de1a49e565ea134556a2025-08-20T03:48:15ZengSpringerOpenJournal of the Egyptian National Cancer Institute2589-04092025-05-0137111110.1186/s43046-025-00293-zEffectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic reviewBima Indra0Nur Qodir1Didit Pramudhito2Legiran Legiran3Zen Hafy4Andi M Iqbal Yusran5Faculty of Medicine, University of SriwijayaDepartment of Surgery, University of Sriwijaya/ Mohammad Hoesin General HospitalDepartment of Surgery, University of Sriwijaya/ Mohammad Hoesin General HospitalDepartment of Biomedicine, University of SriwijayaDepartment of Biomedicine, University of SriwijayaNuclear Medicine Division, Department of Oncology, Mohammad Hoesin General HospitalAbstract Background The effectiveness of radioiodine therapy (RAI) in reducing recurrence and improving overall survival in differentiated thyroid carcinoma (DTC) remains debated. This systematic review evaluates the impact of RAI on DTC recurrence and survival. Methods A comprehensive search was conducted across PubMed, ScienceDirect, Web of Science, CINAHL, and Tripdatabase, including studies from inception to August 2024. Only studies published in English with full-text availability were included. Risk of bias was assessed using the Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions (RoBANS 2). Results Nine studies were included, involving 161,703 participants (36,658 men and 125,045 women). The studies were geographically diverse, with four from the American continent, three from Asia, and two from Europe. RAI doses ranged from 30 to 300 mCi, with 30 mCi and 100 mCi being the most common. Five studies found that RAI reduced recurrence, while two found no significant effect. The median time to recurrence ranged from 10 months to 15 years, with most studies indicating a 1–2-year median. Regarding overall survival, two studies reported improvement with successful RAI therapy, while two found no significant impact. Conclusion RAI therapy shows potential in reducing recurrence in DTC, particularly within the first 2-year post-treatment, but its effect on overall survival remains unclear. Further high-quality research is necessary to confirm these findings and guide clinical practice.https://doi.org/10.1186/s43046-025-00293-zDifferentiated thyroid carcinomaRadioiodine therapyThyroglobulinPapillary thyroid carcinoma |
| spellingShingle | Bima Indra Nur Qodir Didit Pramudhito Legiran Legiran Zen Hafy Andi M Iqbal Yusran Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review Journal of the Egyptian National Cancer Institute Differentiated thyroid carcinoma Radioiodine therapy Thyroglobulin Papillary thyroid carcinoma |
| title | Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review |
| title_full | Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review |
| title_fullStr | Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review |
| title_full_unstemmed | Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review |
| title_short | Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review |
| title_sort | effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma a systematic review |
| topic | Differentiated thyroid carcinoma Radioiodine therapy Thyroglobulin Papillary thyroid carcinoma |
| url | https://doi.org/10.1186/s43046-025-00293-z |
| work_keys_str_mv | AT bimaindra effectivenessofradioiodinetherapyonpreventingrecurrenceindifferentiatedthyroidcarcinomaasystematicreview AT nurqodir effectivenessofradioiodinetherapyonpreventingrecurrenceindifferentiatedthyroidcarcinomaasystematicreview AT diditpramudhito effectivenessofradioiodinetherapyonpreventingrecurrenceindifferentiatedthyroidcarcinomaasystematicreview AT legiranlegiran effectivenessofradioiodinetherapyonpreventingrecurrenceindifferentiatedthyroidcarcinomaasystematicreview AT zenhafy effectivenessofradioiodinetherapyonpreventingrecurrenceindifferentiatedthyroidcarcinomaasystematicreview AT andimiqbalyusran effectivenessofradioiodinetherapyonpreventingrecurrenceindifferentiatedthyroidcarcinomaasystematicreview |